Results 21 to 30 of about 633,245 (221)

Alternative Loop Diuretics to Treat Congestive Heart Failure in Canines [PDF]

, 2022
This literature review will focus on the most used loop diuretics to treat symptoms associated with congestive heart failure in canines. Loop diuretics are a powerful diuretic that work to increase sodium and water excretion by inhibiting the NKCC2 co ...
Solberg, Kaitlynn
core   +1 more source

Diuretics in chronic kidney disease [PDF]

, 2020
The issues of diuretic therapy in patients with chronic kidney disease, pharmacokinetics of diuretics, the problem of diuretic resistance, the tactics of using thiazides and loop diuretics in patients with various stages of chronic kidney disease ...
A. I. Dyadyk, G. G. Taradin, V. I. Merkuriev, Yu. V. Suliman, S. R. Zborovskyy   +4 more
core   +1 more source

Use of diuretics and risk of incident gout : Population-based case-control study [PDF]

, 2014
Objective: Use of diuretics has been associated with an increased risk of gout. Data for different types of diuretics are scarce. This study investigated the association between use of loop diuretics, thiazide or thiazide-like diuretics, and potassium ...
Meier, Christoph R., Jick, Susan S, Christoph R. Meier, Bodmer, Michael, Meier, Christoph R, Saskia Bruderer, Michael Bodmer, Susan S. Jick, Jick, Susan S., Bruderer, Saskia, Bodmer M, Jick SS, Meier CR, Bruderer S   +13 more
core   +1 more source

Loop diuretics are open-channel blockers of the cystic fibrosis transmembrane conductance regulator with distinct kinetics [PDF]

, 2014
Background and Purpose Loop diuretics are widely used to inhibit the Na+, K+, 2Cl- co-transporter, but they also inhibit the cystic fibrosis transmembrane conductance regulator (CFTR) Cl - channel.
Sheppard, David N., Scott-Ward, Toby S., David N Sheppard, Cai, Zhiwei, Min Ju, Khuituan, Pissared, Li, Hongyu, Pissared Khuituan, Toby S Scott‐Ward, Stephen M Husbands, Hongyu Li, Husbands, Stephen M., Liu, J, Sheppard, David N, Jia Liu, Scott-ward, Toby S, Zhiwei Cai, Ju, Min, Liu, Jia, Husbands, Stephen M; id_orcid   +19 more
core   +1 more source

The types of diuretics thought standard by respondents who had chosen loop diuretics ± aldosterone antagonists.

, 2019
(A) The “start with loop diuretics only and increase if necessary” group. (B) The “start with loop diuretics only and add aldosterone antagonists if necessary” group.
Satoru Iwase (779900), Hiroto Ishiki (779912), Yoshiaki Kanai (779904), Isseki Maeda (7181102)   +3 more
core   +1 more source

The potential toxicity of loop diuretics in patients with cardiovascular complications [PDF]

, 2018
A patient with cardiovascular complications is a proper candidate for a diuretic treatment. Here, loop diuretics are the drugs with the greatest strength and time of acting, especially when used in urgent cases like exacerbation of heart failure is ...
Karolina Długi, Długi, Karolina, Rewerski, Sebastian, Mateusz Ozorowski, Wiciński, Michał, Grzegorz Liczner, Michał Wiciński, Sebastian Rewerski, Ozorowski, Mateusz, Bartosz Malinowski, Malinowski, Bartosz, Liczner, Grzegorz   +11 more
core   +1 more source

Ototoxic effects and mechanisms of loop diuretics

, 2016
Over the past two decades considerable progress has been made in understanding the ototoxic effects and mechanisms underlying loop diuretics. As typical representative of loop diuretics ethacrynic acid or furosemide only induces temporary hearing loss ...
Hong Liu, Yongqi Li, Xuewen Wu, Richard Salvi, Hong Sun, Dalian Ding, Haiyan Jiang, Kenneth Gross, Weidong Qi   +8 more
core   +1 more source

Diuretics in pediatrics

, 2023
Diuretics are frequently prescribed drugs and help managing several pathological conditions, including acute and chronic kidney disease, nephrotic syndrome, congestive heart failure, ascites, systemic and pulmonary hypertension.
Chiara Zollinger, Lava, SAG, Damien Schaffner, Sekarski, N., Di Bernardo, S., Stefano Di Bernardo, Nicole Sekarski, Schaffner, D., Sebastiano A. G. Lava, Chehade, H., Hassib Chehade, Zollinger, C.   +11 more
core   +1 more source

Trends in 25 years of antihypertensive agent utilization in Croatia – an alert for scientific community and healthcare providers

British Journal of Clinical Pharmacology, EarlyView.
Aims Hypertension is a leading modifiable risk factor for cardiovascular mortality worldwide. This study aimed to evaluate 25‐year trends in antihypertensive agent (AHA) utilization in Croatia between 2000 and 2024. Methods We conducted a national, population‐based analysis using IMS and IQVIA pharmaceutical databases.
Andrej Belančić, Marta Kučan Štiglić, Ana Jelaković, Bojan Jelaković, Dinko Vitezić   +4 more
wiley   +1 more source

Blood pressure effects of SGLT2 inhibitors and GLP‐1 receptor agonists: Mechanisms, trial evidence and Real‐world data

British Journal of Clinical Pharmacology, EarlyView.
SGLT2 inhibitors and GLP‐1 receptor agonists modestly lower blood pressure across diverse patient populations, including those without diabetes. These effects appear largely independent of glycaemic control and offer additive value in high‐risk patients with overlapping comorbidities.
Andrej Belančić, Yusuf Ziya Sener, Marijana Vučković, Joseph Edgar Blais, Almir Fajkić, Emina Sher, Mislav Radić, Josipa Radić   +7 more
wiley   +1 more source